Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Rosana Simón-Vázquez, Mercedes Peleteiro & África González-Fernández. (2020) Polymeric nanostructure vaccines: applications and challenges. Expert Opinion on Drug Delivery 17:7, pages 1007-1023.
Read now
Read now
Anis Askarizadeh, Ali Badiee & Ali Khamesipour. (2020) Development of nano-carriers for Leishmania vaccine delivery. Expert Opinion on Drug Delivery 17:2, pages 167-187.
Read now
Read now
Shaohui Qiu, Qiang Wei, Zhenglun Liang, Guanghui Ma, Lianyan Wang, Wenqi An, Xiaowei Ma, Xin Fang, Peng He, Hemin Li & Zhongyu Hu. (2014) Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen. Human Vaccines & Immunotherapeutics 10:8, pages 2350-2356.
Read now
Read now
Antu K Dey, Padma Malyala & Manmohan Singh. (2014) Physicochemical and functional characterization of vaccine antigens and adjuvants. Expert Review of Vaccines 13:5, pages 671-685.
Read now
Read now
Ana Paula Barcelos Reinaque, Eduardo Luzía França, Edson Fredulin Scherer, Mayra Aparecida Côrtes, Francisco José Dutra Souto & Adenilda Cristina Honorio-França. (2012) Natural material adsorbed onto a polymer to enhance immune function. Drug Design, Development and Therapy 6, pages 209-216.
Read now
Read now
Lipika Chablani, Suprita A. Tawde & Martin J. D'souza. (2012) Spray-dried microparticles: a potential vehicle for oral delivery of vaccines. Journal of Microencapsulation 29:4, pages 388-397.
Read now
Read now
Delaram Doroud & Sima Rafati. (2012) Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems. Expert Review of Vaccines 11:1, pages 69-86.
Read now
Read now
Siddhartha Jain, Derek T O’Hagan & Manmohan Singh. (2011) The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant. Expert Review of Vaccines 10:12, pages 1731-1742.
Read now
Read now
Ana Maria Carmona-Ribeiro. (2010) Biomimetic nanoparticles: preparation, characterization and biomedical applications. International Journal of Nanomedicine 5, pages 249-259.
Read now
Read now
Barbara C. Baudner & Derek T. O’Hagan. (2010) Bioadhesive delivery systems for mucosal vaccine delivery. Journal of Drug Targeting 18:10, pages 752-770.
Read now
Read now
Moses O Oyewumi, Amit Kumar & Zhengrong Cui. (2010) Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Review of Vaccines 9:9, pages 1095-1107.
Read now
Read now
Matthew Paul & Julian K-C Ma. (2010) Plant-made immunogens and effective delivery strategies. Expert Review of Vaccines 9:8, pages 821-833.
Read now
Read now
Kai Zhao, Guo-Xin Li, Yuan-Yuan Jin, Hai-Xia Wei, Qing-Shen Sun, Ting-Ting Huang, Yun-Feng Wang & Guang-Zhi Tong. (2010) Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres. Journal of Microencapsulation 27:2, pages 178-186.
Read now
Read now
Chandana Mohanty, Geetanjali Arya, RamaS. Verma & SanjeebK. Sahoo. (2009) Nanobiotechnology: Application of Nanotechnology in Therapeutics and Diagnosis. International Journal of Green Nanotechnology: Biomedicine 1:1, pages B24-B38.
Read now
Read now
H. Çiğdem Arca, Merve Günbeyaz & Sevda Şenel. (2009) Chitosan-based systems for the delivery of vaccine antigens. Expert Review of Vaccines 8:7, pages 937-953.
Read now
Read now
Manmohan Singh, Aravind Chakrapani & Derek O’Hagan. (2007) Nanoparticles and microparticles as vaccine-delivery systems. Expert Review of Vaccines 6:5, pages 797-808.
Read now
Read now
Ed C Lavelle & D T O’Hagan. (2006) Delivery systems and adjuvants for oral vaccines. Expert Opinion on Drug Delivery 3:6, pages 747-762.
Read now
Read now
Maria A. Dea-Ayuela, Sara Rama-Iñiguez, S. Torrado-Santiago & F. Bolas-Fernandez. (2006) Microcapsules formulated in the enteric coating copolymer Eudragit L100 as delivery systems for oral vaccination against infections by gastrointestinal nematode parasites. Journal of Drug Targeting 14:8, pages 567-575.
Read now
Read now
Wilson S Meng & Lisa H Butterfield. (2005) Activation of antigen-presenting cells by DNA delivery vectors. Expert Opinion on Biological Therapy 5:8, pages 1019-1028.
Read now
Read now
Indresh K Srivastava, Jeffrey B Ulmer & Susan W Barnett. (2004) Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design. Expert Review of Vaccines 3:sup1, pages S33-S52.
Read now
Read now
Jeffrey B Ulmer. (2004) Enhancement of vaccine potency through improved delivery. Expert Opinion on Biological Therapy 4:7, pages 1045-1051.
Read now
Read now
Articles from other publishers (148)
Jorge Huete‐Carrasco, Roisin I. Lynch, Ross W. Ward & Ed C. Lavelle. (2023) Rational design of polymer‐based particulate vaccine adjuvants. European Journal of Immunology.
Crossref
Crossref
Selin Parmaksız, Mert Pekcan, Aykut Özkul, Ece Türkmen, Vanessa Rivero-Arredondo, Luis Ontiveros-Padilla, Neil Forbes, Yvonne Perrie, Constantino López-Macías & Sevda Şenel. (2023) In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles. International Journal of Pharmaceutics 648, pages 123568.
Crossref
Crossref
Yechun Jiang, Chengcheng Feng, Wanni Wang, Haisheng Qian & Lingling Xu. (2023) Recent Advances in the Multifunctional Microneedles: From Design to Cancer Preventing, Diagnosis, and Treatment. Advanced Materials Technologies 8:19.
Crossref
Crossref
Mahmoud M. Abotaleb, Heba M. Soliman, Rasha G. Tawfik, Ahlam Mourad, Riad H. Khalil & Hany M.R. Abdel-Latif. (2023) Efficacy of combined inactivated vaccines against Vibrio alginolyticus and Streptococcus agalactiae infections in Nile tilapia in Egypt. Aquaculture International.
Crossref
Crossref
Nihal Mulla, Lipika Chablani, Ashwin C. Parenky & Martin J. D’Souza. (2023) Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide. Vaccines 11:3, pages 543.
Crossref
Crossref
Rahul Ahuja, Sudeepa Srichandan, Jairam Meena, Bichitra Kumar Biswal & Amulya K. Panda. (2023) Immunogenicity Evaluation of Thermostable Microparticles Entrapping Receptor Binding Domain of SARS-CoV-2 by Single Point Administration. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Smital Patil, Sharon Vijayanand, Devyani Joshi, Ipshita Menon, Keegan Braz Gomes, Akanksha Kale, Priyal Bagwe, Shadi Yacoub, Mohammad N. Uddin & Martin J. D'Souza. (2023) Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model. International Journal of Pharmaceutics 632, pages 122583.
Crossref
Crossref
Selin Parmaksız, Aytül Gül, Sedef Erkunt Alak, Muhammet Karakavuk, Hüseyin Can, Ceren Gül, Tuğba Karakavuk, Constantino López-Macías, Nuhan Puralı, Mert Döşkaya & Sevda Şenel. (2022) Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system. International Journal of Pharmaceutics 626, pages 122199.
Crossref
Crossref
Trinh Phuong Vo, Gitika Panicker, Kimberly Braz-Gomes, Ashwin C. Parenky, Ira Rajbhandari, Mangalathu S. Rajeevan, Elizabeth R. Unger, Martin J. D’Souza & Mohammad N. Uddin. (2022) Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route. Pharmaceuticals 15:9, pages 1128.
Crossref
Crossref
Rahul Ahuja, Asha Shelly, Jairam Meena, Mamta Singh, Devinder Sehgal & Amulya K. Panda. (2022) Enhanced immunogenicity of recombinant pneumococcal protein delivered using thermostable polymer particles. Materials Today Communications 32, pages 103894.
Crossref
Crossref
Rahul Ahuja, Asha Shelly, Jairam Meena & Amulya K. Panda. (2022) Microparticles entrapping pneumococcal protein SP0845 show improved immunogenicity and temperature stability. International Journal of Biological Macromolecules 203, pages 661-670.
Crossref
Crossref
Helena Freire Haddad, Jacqueline A. Burke, Evan A. Scott & Guillermo A. Ameer. (2021) Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies. Regenerative Engineering and Translational Medicine 8:1, pages 32-42.
Crossref
Crossref
Keegan Braz Gomes, Bernadette D'Souza, Sharon Vijayanand, Ipshita Menon & Martin J. D'Souza. (2022) A dual-delivery platform for vaccination using antigen-loaded nanoparticles in dissolving microneedles. International Journal of Pharmaceutics 613, pages 121393.
Crossref
Crossref
Brandi T. Johnson-Weaver, Hae Woong Choi, Hang Yang, Josh A. Granek, Cliburn Chan, Soman N. Abraham & Herman F. Staats. (2021) Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens. Frontiers in Immunology 12.
Crossref
Crossref
E. Afsharipour, M.J. Zorriehzahra, Gh Azari Takami, Sh Kakoolaki, A.A. Motallebi, I. Sharifpour, C. Faggio, A. Filippo Peritore & D. Di Paola. (2021) An investigation on protective effects of the new killed vaccine against nervous necrosis virus (NNV) using histopathology and immunohistochemistry approach on the brain and eye tissues of Acipenser stellatus Pallas 1771. Fish & Shellfish Immunology 116, pages 91-97.
Crossref
Crossref
Pragya Prasanna, Prakash Kumar, Saurabh Kumar, Vinod Kumar Rajana, Vishnu Kant, Surendra Rajit Prasad, Utpal Mohan, V. Ravichandiran & Debabrata Mandal. (2021) Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis – A review. Biomedicine & Pharmacotherapy 141, pages 111920.
Crossref
Crossref
Devyani Joshi, Christiane Chbib, Mohammad N. Uddin & Martin J. D’Souza. (2021) Evaluation of Microparticulate (S)-4,5-Dihydroxy-2,3-pentanedione (DPD) as a Potential Vaccine Adjuvant. The AAPS Journal 23:4.
Crossref
Crossref
Mengdie Li, Lisa M. Kaminskas & Nirmal Marasini. (2021) Recent advances in nano/microparticle-based oral vaccines. Journal of Pharmaceutical Investigation 51:4, pages 425-438.
Crossref
Crossref
Weiwei Zeng, Yingying Wang, Huzi Hu, Qing Wang, Sven M. Bergmann, Yahui Wang, Bo Li, Yuefeng Lv, Hua Li, Jiyuan Yin & Yingying Li. (2021) Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia. Vaccines 9:2, pages 86.
Crossref
Crossref
Selin Parmaksız & Sevda Şenel. 2021. Chitosan for Biomaterials IV. Chitosan for Biomaterials IV
293
379
.
Stefanie Thalhauser, David Peterhoff, Ralf Wagner & Miriam Breunig. (2020) Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery. European Journal of Pharmaceutics and Biopharmaceutics 156, pages 1-10.
Crossref
Crossref
Rahul Ahuja, Neha Panwar, Jairam Meena, Mamta Singh, Debi P. Sarkar & Amulya K. Panda. (2020) Natural products and polymeric nanocarriers for cancer treatment: a review. Environmental Chemistry Letters 18:6, pages 2021-2030.
Crossref
Crossref
Ana Maria Carmona-Ribeiro & Yunys Pérez-Betancourt. (2020) Cationic Nanostructures for Vaccines Design. Biomimetics 5:3, pages 32.
Crossref
Crossref
Selin Yüksel, Mert Pekcan, Nuhan Puralı, Güneş Esendağlı, Ece Tavukçuoğlu, Vanessa Rivero-Arredondo, Luis Ontiveros-Padilla, Constantino López-Macías & Sevda Şenel. (2020) Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosan. International Journal of Pharmaceutics 578, pages 119129.
Crossref
Crossref
Xinyue Huang, Danielle Paixão Cavalcante & Helen E Townley. (2020) Macrophage-like THP-1 cells show effective uptake of silica nanoparticles carrying inactivated diphtheria toxoid for vaccination. Journal of Nanoparticle Research 22:1.
Crossref
Crossref
Rahul Ahuja, Neha Panwar, Jairam Meena, Debi P. Sarkar & Amulya K. Panda. 2020. Sustainable Agriculture Reviews 43. Sustainable Agriculture Reviews 43
67
112
.
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2020. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
285
315
.
Seyed Mohammad Gheibi Hayat & Majid Darroudi. (2019) Nanovaccine: A novel approach in immunization. Journal of Cellular Physiology 234:8, pages 12530-12536.
Crossref
Crossref
Ahmad Mehravaran, Maryam Rezaei Nasab, Hadi Mirahmadi, Iraj Sharifi, Ebrahim Alijani, Amin Reza Nikpoor & Javad Akhtari. (2019) Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis. Infection, Genetics and Evolution 70, pages 27-35.
Crossref
Crossref
Raymonde B. Bekale, Su-Mari Du Plessis, Nai-Jen Hsu, Jyoti R. Sharma, Samantha L. Sampson, Muazzam Jacobs, Mervin Meyer, Gene D. Morse & Admire Dube. (2018) Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines. Pharmaceutical Research 36:1.
Crossref
Crossref
Thomas Ebensen, Barbara Fuchs, Kai Schulze & Carlos Alberto Guzmán. 2018. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids
1
31
.
Majela González-Miró, Anna-Maria Radecker, Laura M. Rodríguez-Noda, Mildrey Fariñas-Medina, Caridad Zayas-Vignier, Mabel Hernández-Cedeño, Yohana Serrano, Félix Cardoso, Darielys Santana-Mederos, Dagmar García-Rivera, Yury Valdés-Balbín, Vicente Vérez-Bencomo & Bernd H. A. Rehm. (2018) Design and Biological Assembly of Polyester Beads Displaying Pneumococcal Antigens as Particulate Vaccine. ACS Biomaterials Science & Engineering 4:9, pages 3413-3424.
Crossref
Crossref
Sunita Minz & Ravi Shankar Pandey. (2017) Lipid A adjuvanted Chylomicron Mimicking Solid Fat Nanoemulsions for Immunization Against Hepatitis B. AAPS PharmSciTech 19:3, pages 1168-1181.
Crossref
Crossref
Solmaz Dehghan, Masoumeh Tavassoti Kheiri, Khalil Abnous, Maryam Eskandari & Mohsen Tafaghodi. (2018) Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits. Microbial Pathogenesis 115, pages 74-85.
Crossref
Crossref
Issei Takeuchi, Yoshihiro Taniguchi, Yuki Tamura, Kazuhiro Ochiai & Kimiko Makino. (2018) Effects of l-leucine on PLGA microparticles for pulmonary administration prepared using spray drying: Fine particle fraction and phagocytotic ratio of alveolar macrophages. Colloids and Surfaces A: Physicochemical and Engineering Aspects 537, pages 411-417.
Crossref
Crossref
Reshma J. Nevagi, Istvan Toth & Mariusz Skwarczynski. 2018. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Peptide Applications in Biomedicine, Biotechnology and Bioengineering
327
358
.
Aubrey Davis, Lauren T. Crum, Lynette B. Corbeil & Mark Hildebrand. (2017) Expression of Histophilus somni IbpA DR2 protective antigen in the diatom Thalassiosira pseudonana. Applied Microbiology and Biotechnology 101:13, pages 5313-5324.
Crossref
Crossref
Jee Youn Hwang, Mun-Gyeong Kwon, Yu Jin Kim, Sung-Hee Jung, Myoung-Ae Park & Maeng-Hyun Son. (2017) Montanide IMS 1312 VG adjuvant enhances the efficacy of immersion vaccine of inactivated viral hemorrhagic septicemia virus (VHSV) in olive flounder, Paralichthys olivaceus. Fish & Shellfish Immunology 60, pages 420-425.
Crossref
Crossref
N. Mody, R. Sharma, S. Dubey & S.P. Vyas. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
259
278
.
Suprita A. Tawde, Lipika Chablani, Archana Akalkotkar & Martin J. D'Souza. (2016) Evaluation of microparticulate ovarian cancer vaccine via transdermal route of delivery. Journal of Controlled Release 235, pages 147-154.
Crossref
Crossref
Cristina Bruno, Valentina Agnolon, Francesco Berti, Simone Bufali, Derek T. O’Hagan & Barbara C. Baudner. (2016) The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine. European Journal of Pharmaceutics and Biopharmaceutics 105, pages 1-8.
Crossref
Crossref
Naomi Benne, Janine van Duijn, Johan Kuiper, Wim Jiskoot & Bram Slütter. (2016) Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. Journal of Controlled Release 234, pages 124-134.
Crossref
Crossref
Filipa Lebre, Claire H. Hearnden & Ed C. Lavelle. (2016) Modulation of Immune Responses by Particulate Materials. Advanced Materials 28:27, pages 5525-5541.
Crossref
Crossref
Faez Amokrane Nait Mohamed & Fatima Laraba-Djebari. (2016) Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming. Vaccine 34:24, pages 2692-2699.
Crossref
Crossref
Iraj Khalili, Rahim Ghadimipour, Saeed Sadigh Eteghad, Mohsen Fathi Najafi, Mohammad Majid Ebrahimi, Naser Godsian, Yousef Sefidi Heris & Mohammad Taghi Khalili. (2015) Evaluation of Immune Response Against Inactivated Avian Influenza (H9N2) Vaccine, by Using Chitosan Nanoparticles. Jundishapur Journal of Microbiology 8:12.
Crossref
Crossref
Elizabeth González AznarBelkis RomeuMiriam LastreCaridad ZayasMaribel CuelloOsmir CabreraYolanda ValdezMildrey FariñasOliver Pérez. (2015) Mucosal and systemic immune responses induced by a single time vaccination strategy in mice. Canadian Journal of Microbiology 61:8, pages 531-538.
Crossref
Crossref
Rikhav Gala, Ruhi Ubale, Martin D'Souza & Susu Zughaier. 2015. Nanoparticulate Vaccine Delivery Systems. Nanoparticulate Vaccine Delivery Systems
127
140
.
Bernadette D'Souza, Prathap Shastri, Gabrielle Hammons, Lakshmi Kolluru, Nihal Mulla & Gowrisankar Rajam. 2015. Nanoparticulate Vaccine Delivery Systems. Nanoparticulate Vaccine Delivery Systems
115
126
.
Trinh Vo, Rikhav Gala, Thripthy Chandran, Sucheta D'Sa & Ruhi Ubale. 2015. Nanoparticulate Vaccine Delivery Systems. Nanoparticulate Vaccine Delivery Systems
15
59
.
Lipika Chablani, Nihal Mulla, Periasamy Selvaraj & Martin D'Souza. 2015. Nanoparticulate Vaccine Delivery Systems. Nanoparticulate Vaccine Delivery Systems
171
184
.
Adam A Walters, Christos Krastev, Adrian V S Hill & Anita Milicic. (2015) Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy. Journal of Pharmacy and Pharmacology 67:3, pages 400-408.
Crossref
Crossref
Justin R. Adams, Shannon L. Haughney & Surya K. Mallapragada. (2015) Effective polymer adjuvants for sustained delivery of protein subunit vaccines. Acta Biomaterialia 14, pages 104-114.
Crossref
Crossref
Martin J. D’Souza, Rikhav P. Gala, Ruhi V. Ubale, Bernadette D’Souza, Trinh Phuong Vo, Ashwin C. Parenky, Nihal S. Mulla, Sucheta D’Sa, Marissa D’Souza, Kim Braz-Gomes, Nigel D’Souza, Maurizio Chiriva-Internati & Susu Zughaier. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
89
122
.
Vincent Pavot, Morgane Berthet, Julien Rességuier, Sophie Legaz, Nadège Handké, Sarah C Gilbert, Stéphane Paul & Bernard Verrier. (2014)
Poly(lactic acid) and poly(lactic-
co
-glycolic acid) particles as versatile carrier platforms for vaccine delivery
. Nanomedicine 9:17, pages 2703-2718.
Crossref
Crossref
Xiaoming Chen, Lianyan Wang, Qi Liu, Jilei Jia, Yuan Liu, Weifeng Zhang, Guanghui Ma & Zhiguo Su. (2014) Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes. International Immunopharmacology 23:2, pages 592-602.
Crossref
Crossref
Faeze Eskandari, Ghazal Alipour Talesh, Maryam Parooie, Mahmoud Reza Jaafari, Ali Khamesipour, Zahra Saberi, Azam Abbasi & Ali Badiee. (2014) Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis. Experimental Parasitology 146, pages 78-86.
Crossref
Crossref
Sarfaraz K. Niazi. 2014. Handbook of Bioequivalence Testing. Handbook of Bioequivalence Testing
756
787
.
Weifeng Zhang, Lianyan Wang, Yuan Liu, Xiaoming Chen, Jiahui Li, Tingyuan Yang, Wenqi An, Xiaowei Ma, Ruowen Pan & Guanghui Ma. (2013) Comparison of PLA Microparticles and Alum as Adjuvants for H5N1 Influenza Split Vaccine: Adjuvanticity Evaluation and Preliminary Action Mode Analysis. Pharmaceutical Research 31:4, pages 1015-1031.
Crossref
Crossref
Akiko Kiriyama, Katsumi Iga & Nobuhito Shibata. (2013) Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery. Therapeutic Delivery 4:10, pages 1261-1278.
Crossref
Crossref
Amit A. Lugade, Dhruba J. Bharali, Vandana Pradhan, Galina Elkin, Shaker A. Mousa & Yasmin Thanavala. (2013) Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity. Nanomedicine: Nanotechnology, Biology and Medicine 9:7, pages 923-934.
Crossref
Crossref
Shiyu Yan, Wenyi Gu & Zhi Ping Xu. (2013) Re-considering how particle size and other properties of antigen–adjuvant complexes impact on the immune responses. Journal of Colloid and Interface Science 395, pages 1-10.
Crossref
Crossref
Sheva Naahidi, Mousa Jafari, Faramarz Edalat, Kevin Raymond, Ali Khademhosseini & P. Chen. (2013) Biocompatibility of engineered nanoparticles for drug delivery. Journal of Controlled Release 166:2, pages 182-194.
Crossref
Crossref
Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour & Mahmoud Reza Jaafari. (2013) Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends. Vaccine 31:5, pages 735-749.
Crossref
Crossref
J.F. Correia-Pinto, N. Csaba & M.J. Alonso. (2013) Vaccine delivery carriers: Insights and future perspectives. International Journal of Pharmaceutics 440:1, pages 27-38.
Crossref
Crossref
L. León-Rodríguez, A. Luzardo-Álvarez, J. Blanco-Méndez, J. Lamas & J. Leiro. (2013) Biodegradable microparticles covalently linked to surface antigens of the scuticociliate parasite P. dicentrarchi promote innate immune responses in vitro. Fish & Shellfish Immunology 34:1, pages 236-243.
Crossref
Crossref
Claire Hearnden & Ed C. Lavelle. 2013. Cancer Immunotherapy. Cancer Immunotherapy
333
349
.
Zoraida P. Aguilar. 2013. Nanomaterials for Medical Applications. Nanomaterials for Medical Applications
409
451
.
Zoraida P. Aguilar. 2013. Nanomaterials for Medical Applications. Nanomaterials for Medical Applications
361
408
.
Zoraida P. Aguilar. 2013. Nanomaterials for Medical Applications. Nanomaterials for Medical Applications
293
360
.
Olga Borges & Gerrit Borchard. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
65
80
.
Jardin Leleux & Krishnendu Roy. (2013) Micro and Nanoparticle-Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective. Advanced Healthcare Materials 2:1, pages 72-94.
Crossref
Crossref
Prathap Nagaraja Shastri, Min‐Chul Kim, Fu‐Shi Quan, Martin J. D'Souza & Sang‐Moo Kang. (2012) Immunogenicity and protection of oral influenza vaccines formulated into microparticles. Journal of Pharmaceutical Sciences 101:10, pages 3623-3635.
Crossref
Crossref
Fiona A. Sharp & Ed C. Lavelle. 2012. Vaccinology. Vaccinology
361
374
.
Hua-shan Shi, Chang-yang Gong, Hai-long Zhang, Yong-sheng Wang, Jing Zhang, Zi-chao Luo, Zhi-yong Qian, Yu-quan Wei & Li Yang. (2012) Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity. Carbohydrate Polymers 89:4, pages 1101-1109.
Crossref
Crossref
L. León-Rodríguez, A. Luzardo-Álvarez, J. Blanco-Méndez, J. Lamas & J. Leiro. (2012) A vaccine based on biodegradable microspheres induces protective immunity against scuticociliatosis without producing side effects in turbot. Fish & Shellfish Immunology 33:1, pages 21-27.
Crossref
Crossref
Susanne C Diesner, Xue-Yan WangErika Jensen-JarolimEva Untersmayr & Franz Gabor. (2012) Use of lectin-functionalized particles for oral immunotherapy. Therapeutic Delivery 3:2, pages 277-290.
Crossref
Crossref
Rajesh Kumar Gupta, Dinesh G. Goswami, Rajiv R. Singh, Avadhesha Surolia & Amulya K. Panda. (2012) Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization. European Journal of Pharmaceutical Sciences 45:3, pages 282-295.
Crossref
Crossref
Hidehiko Suzuki, Masuo Kondoh, Hideki Kakutani, Seiji Yamane, Hiroshi Uchida, Takao Hamakubo & Kiyohito Yagi. (2012) The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice. Biomaterials 33:1, pages 317-324.
Crossref
Crossref
Sevda Şenel. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery
517
532
.
Shayne Cox GadFiona A. Sharp & Ed C. Lavelle. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Kae Pusic, Hengyi Xu, Andrew Stridiron, Zoraida Aguilar, Andrew Wang & George Hui. (2011) Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies. Vaccine 29:48, pages 8898-8908.
Crossref
Crossref
Roberto Nicolete, Daiane F. dos Santos & Lúcia H. Faccioli. (2011) The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. International Immunopharmacology 11:10, pages 1557-1563.
Crossref
Crossref
K. DEBACHE, C. KROPF, C. A. SCHÜTZ, L. J. HARWOOD, P. KÄUPER, T. MONNEY, N. ROSSI, C. LAUE, K. C. McCULLOUGH & A. HEMPHILL. (2011) Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites. Parasite Immunology 33:2, pages 81-94.
Crossref
Crossref
Stefaan De Koker, Bart N. Lambrecht, Monique A. Willart, Yvette van Kooyk, Johan Grooten, Chris Vervaet, Jean Paul Remon & Bruno G. De Geest. (2011) Designing polymeric particles for antigen delivery. Chem. Soc. Rev. 40:1, pages 320-339.
Crossref
Crossref
Sevda Şenel. 2011. Chitosan for Biomaterials I. Chitosan for Biomaterials I
111
137
.
Deepa Mohanan, Bram Slütter, Malou Henriksen-Lacey, Wim Jiskoot, Joke A. Bouwstra, Yvonne Perrie, Thomas M. Kündig, Bruno Gander & Pål Johansen. (2010) Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. Journal of Controlled Release 147:3, pages 342-349.
Crossref
Crossref
SHARDOOL JAIN, HUSAIN ATTARWALA & MANSOOR AMIJI. (2012) NON-CONDENSING POLYMERIC GENE DELIVERY SYSTEMS: PRINCIPLES AND APPLICATIONS. Nano LIFE 01:03n04, pages 219-237.
Crossref
Crossref
Wendy C. Weinberg, Linan Ha, Susan L. Kirshner & Daniela I. Verthelyi. 2010. Aggregation of Therapeutic Proteins. Aggregation of Therapeutic Proteins
435
451
.
Olga Borges, Filipa Lebre, Dulce Bento, Gerrit Borchard & Hans E. Junginger. (2009) Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers. Pharmaceutical Research 27:2, pages 211-223.
Crossref
Crossref
Stefaan De Koker, Thomas Naessens, Bruno G. De Geest, Pieter Bogaert, Jo Demeester, Stefaan De Smedt & Johan Grooten. (2010) Biodegradable Polyelectrolyte Microcapsules: Antigen Delivery Tools with Th17 Skewing Activity after Pulmonary Delivery. The Journal of Immunology 184:1, pages 203-211.
Crossref
Crossref
T. Ebensen, B. Fuchs, K. Schulze & C. A. Guzmán. 2010. Handbook of Hydrocarbon and Lipid Microbiology. Handbook of Hydrocarbon and Lipid Microbiology
3311
3331
.
Stefaan De Koker, Bruno G. De Geest, Satwinder K. Singh, Riet De Rycke, Thomas Naessens, Yvette Van Kooyk, Jo Demeester, Stefaan C. De Smedt & Johan Grooten. (2009) Polyelectrolyte Microcapsules as Antigen Delivery Vehicles To Dendritic Cells: Uptake, Processing, and Cross‐Presentation of Encapsulated Antigens. Angewandte Chemie International Edition 48:45, pages 8485-8489.
Crossref
Crossref
Stefaan De Koker, Bruno G. De Geest, Satwinder K. Singh, Riet De Rycke, Thomas Naessens, Yvette Van Kooyk, Jo Demeester, Stefaan C. De Smedt & Johan Grooten. (2009) Polyelectrolyte Microcapsules as Antigen Delivery Vehicles To Dendritic Cells: Uptake, Processing, and Cross‐Presentation of Encapsulated Antigens. Angewandte Chemie 121:45, pages 8637-8641.
Crossref
Crossref
Nilton Lincopan, Noelí M. Espíndola, Adelaide J. Vaz, Maria Helena B. da Costa, Eliana Faquim-Mauro & Ana M. Carmona-Ribeiro. (2009) Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo. Vaccine 27:42, pages 5760-5771.
Crossref
Crossref
Vibhu Kanchan, Yogesh K. Katare & Amulya K. Panda. (2009) Memory antibody response from antigen loaded polymer particles and the effect of antigen release kinetics. Biomaterials 30:27, pages 4763-4776.
Crossref
Crossref
Vibhu Kanchan, Yogesh K. Katare & Amulya K. Panda. (2009) Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens. European Journal of Pharmaceutical Sciences 38:1, pages 18-28.
Crossref
Crossref
Antonella Caputo, Arianna Castaldello, Egidio Brocca-Cofano, Rebecca Voltan, Francesca Bortolazzi, Giuseppe Altavilla, Katia Sparnacci, Michele Laus, Luisa Tondelli, Riccardo Gavioli & Barbara Ensoli. (2009) Induction of humoral and enhanced cellular immune responses by novel core–shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration. Vaccine 27:27, pages 3605-3615.
Crossref
Crossref
Arvind K. Jain, Amit K. Goyal, Prem N. Gupta, Kapil Khatri, Neeraj Mishra, Abhinav Mehta, Sharad Mangal & Suresh P. Vyas. (2009) Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. Journal of Controlled Release 136:2, pages 161-169.
Crossref
Crossref
Bruno Guy. 2009. Carbohydrate‐Based Vaccines and Immunotherapies. Carbohydrate‐Based Vaccines and Immunotherapies
89
115
.
Ali Badiee, Mahmoud R. Jaafari, Ali Khamesipour, Afshin Samiei, Dina Soroush, Masoumeh Tavassoti Kheiri, Farzaneh Barkhordari, W. Robert McMaster & Fereidoun Mahboudi. (2009) The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63). Experimental Parasitology 121:4, pages 362-369.
Crossref
Crossref
Nolwenn Brandhonneur, François Chevanne, Véronique Vié, Benoît Frisch, Roselyne Primault, Marie-Frédérique Le Potier & Pascal Le Corre. (2009) Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. European Journal of Pharmaceutical Sciences 36:4-5, pages 474-485.
Crossref
Crossref
Kenneth C. McCullough & Artur Summerfield. (2009) Targeting the porcine immune system—Particulate vaccines in the 21st century. Developmental & Comparative Immunology 33:3, pages 394-409.
Crossref
Crossref
Kaley D. Wilson, Susan D. de Jong & Ying K. Tam. (2009) Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy. Advanced Drug Delivery Reviews 61:3, pages 233-242.
Crossref
Crossref
Jonathan K. Armstrong. 2009. PEGylated Protein Drugs: Basic Science and Clinical Applications. PEGylated Protein Drugs: Basic Science and Clinical Applications
147
168
.
Aurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, Fausto Titti & Barbara Ensoli. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
189
242
.
Samar Hamdy, Aws Alshamsan & John Samuel. 2009. Nanotechnology in Drug Delivery. Nanotechnology in Drug Delivery
519
543
.
Rogério S Rosada, Lucimara Gaziola de la Torre, Fabiani G Frantz, Ana PF Trombone, Carlos R Zárate-Bladés, Denise M Fonseca, Patrícia RM Souza, Izaíra T Brandão, Ana P Masson, Édson G Soares, Simone G Ramos, Lúcia H Faccioli, Célio L Silva, Maria HA Santana & Arlete AM Coelho-Castelo. (2008) Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunology 9:1.
Crossref
Crossref
Sara Gómez, Carlos Gamazo, Beatriz San Roman, Marta Ferrer, Maria Luisa Sanz, Socorro Espuelas & Juan M. Irache. (2008) Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis. European Journal of Pharmaceutics and Biopharmaceutics 70:3, pages 711-717.
Crossref
Crossref
Laura J. Peek, C. Russell Middaugh & Cory Berkland. (2008) Nanotechnology in vaccine delivery. Advanced Drug Delivery Reviews 60:8, pages 915-928.
Crossref
Crossref
Kimberly A. Schoenly & David B. Weiner. (2008) Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform “Spotty Business”. Journal of Virology 82:7, pages 3166-3180.
Crossref
Crossref
Ali Badiee, Mahmoud R. Jaafari, Afshin Samiei, Dina Soroush & Ali Khamesipour. (2008)
Coencapsulation of CpG Oligodeoxynucleotides with Recombinant
Leishmania major
Stress-Inducible Protein 1 in Liposome Enhances Immune Response and Protection against Leishmaniasis in Immunized BALB/c Mice
. Clinical and Vaccine Immunology 15:4, pages 668-674.
Crossref
Crossref
Padma Malyala, James Chesko, Mildred Ugozzoli, Amanda Goodsell, Fengmin Zhou, Michael Vajdy, Derek T. O'Hagan & Manmohan Singh. (2008) The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. Journal of Pharmaceutical Sciences 97:3, pages 1155-1164.
Crossref
Crossref
Raghavendra C. Mundargi, V. Ramesh Babu, Vidhya Rangaswamy, Pradip Patel & Tejraj M. Aminabhavi. (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. Journal of Controlled Release 125:3, pages 193-209.
Crossref
Crossref
H.H. Salman, S. Gómez, C. Gamazo, R. Costa Martins, V. Zabaleta & J.M. Irache. (2008) Micro-organism-like nanoparticles for oral antigen delivery. Journal of Drug Delivery Science and Technology 18:1, pages 31-39.
Crossref
Crossref
Frederick R. Vogel & Stanley L. Hem. 2008. Vaccines. Vaccines
59
71
.
Padma Malyala & Manmohan Singh. 2008. Immunity Against Mucosal Pathogens. Immunity Against Mucosal Pathogens
499
511
.
Vibhu Kanchan & Amulya K. Panda. (2007) Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 28:35, pages 5344-5357.
Crossref
Crossref
Rebecca Voltan, Arianna Castaldello, Egidio Brocca-Cofano, Giuseppe Altavilla, Antonella Caputo, Michele Laus, Katia Sparnacci, Barbara Ensoli, Silvia Spaccasassi, Marco Ballestri & Luisa Tondelli. (2007) Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes. Pharmaceutical Research 24:10, pages 1870-1882.
Crossref
Crossref
Lindsey C. Pingel, Xiaoying Lu & Kim A. Brogden. 2007. Virulence Mechanisms of Bacterial Pathogens. Virulence Mechanisms of Bacterial Pathogens
281
295
.
Samar Hamdy, Azita Haddadi, Vishwa Somayaji, David Ruan & John Samuel. (2007) Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (d,l-lactic-co-glycolic acid) nanoparticle formulations. Journal of Pharmaceutical and Biomedical Analysis 44:4, pages 914-923.
Crossref
Crossref
Bruno Guy. (2007) The perfect mix: recent progress in adjuvant research. Nature Reviews Microbiology 5:7, pages 396-397.
Crossref
Crossref
Sara Gómez, Carlos Gamazo, Beatriz San Roman, Marta Ferrer, Maria Luisa Sanz & Juan M. Irache. (2007) Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens. Vaccine 25:29, pages 5263-5271.
Crossref
Crossref
Weili Yan, Weihsu Chen & Leaf Huang. (2007) Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines. Molecular Immunology 44:15, pages 3672-3681.
Crossref
Crossref
Praveen Elamanchili, Christine M. E. Lutsiak, Samar Hamdy, Manish Diwan & John Samuel. (2007) “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells. Journal of Immunotherapy 30:4, pages 378-395.
Crossref
Crossref
Ali Badiee, Mahmoud R. Jaafari & Ali Khamesipour. (2007) Leishmania major: Immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes. Experimental Parasitology 115:2, pages 127-134.
Crossref
Crossref
Stefan Fischer, Edith Uetz-von Allmen, Ying Waeckerle-Men, Marcus Groettrup, Hans P. Merkle & Bruno Gander. (2007) The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials 28:6, pages 994-1004.
Crossref
Crossref
Jigna D. Patel, Ronan O’Carra, Julia Jones, Jerold G. Woodward & Russell J. Mumper. (2006) Preparation and Characterization of Nickel Nanoparticles for Binding to His-tag Proteins and Antigens. Pharmaceutical Research 24:2, pages 343-352.
Crossref
Crossref
Jun Kunisawa, Jerry R. McGhee & Hiroshi Kiyono. 2007. Mucosal Immune Defense: Immunoglobulin A. Mucosal Immune Defense: Immunoglobulin A
345
389
.
Norman L. Letvin. (2006) Progress and obstacles in the development of an AIDS vaccine. Nature Reviews Immunology 6:12, pages 930-939.
Crossref
Crossref
Janet Wendorf, Manmohan Singh, James Chesko, Jina Kazzaz, Elawati Soewanan, Mildred Ugozzoli & Derek O'Hagan. (2006) A Practical Approach to the use of Nanoparticles for Vaccine Delivery. Journal of Pharmaceutical Sciences 95:12, pages 2738-2750.
Crossref
Crossref
Sarfaraz Niazi. 2006. Handbook of Preformulation. Handbook of Preformulation
241
285
.
Derek T. O’Hagan, Manmohan Singh & Jeffrey B. Ulmer. (2006) Microparticle-based technologies for vaccines. Methods 40:1, pages 10-19.
Crossref
Crossref
Sue D. Xiang, Anja Scholzen, Gabriela Minigo, Cassandra David, Vasso Apostolopoulos, Patricia L. Mottram & Magdalena Plebanski. (2006) Pathogen recognition and development of particulate vaccines: Does size matter?. Methods 40:1, pages 1-9.
Crossref
Crossref
Michael Vajdy, Mark Selby, Angelica Medina-Selby, Doris Coit, John Hall, Laura Tandeske, David Chien, Celine Hu, Domenico Rosa, Manmohan Singh, Jina Kazzaz, Steve Nguyen, Steve Coates, Philip Ng, Sergio Abrignani, Yin-Ling Lin, Michael Houghton & Derek T. O'Hagan. (2006) Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses. Journal of General Virology 87:8, pages 2253-2262.
Crossref
Crossref
Mahmoud R. Jaafari, Attieh Ghafarian, Ahsan Farrokh-Gisour, Afshin Samiei, Masoumeh Tavassoti Kheiri, Fereidoun Mahboudi, Farzaneh Barkhordari, Ali Khamesipour & W. Robert McMaster. (2006) Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine 24:29-30, pages 5708-5717.
Crossref
Crossref
Yogesh K. Katare & Amulya K. Panda. (2006) Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles. European Journal of Pharmaceutical Sciences 28:3, pages 179-188.
Crossref
Crossref
Aviva Joseph, Noga Itskovitz-Cooper, Sarit Samira, Orli Flasterstein, Hagit Eliyahu, Dmitri Simberg, Itzik Goldwaser, Yechezkel Barenholz & Eli Kedar. (2006) A new intranasal influenza vaccine based on a novel polycationic lipid—ceramide carbamoyl-spermine (CCS). Vaccine 24:18, pages 3990-4006.
Crossref
Crossref
Pilar M. Muñoz, Maite Estevan, Clara M. Marín, M. Jesús De Miguel, M. Jesús Grilló, Montserrat Barberán, Juan M. Irache, Jose M. Blasco & Carlos Gamazo. (2006) Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. Vaccine 24:11, pages 1897-1905.
Crossref
Crossref
Jina Kazzaz, Manmohan Singh, Mildred Ugozzoli, James Chesko, Elawati Soenawan & Derek T. O'Hagan. (2006) Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency. Journal of Controlled Release 110:3, pages 566-573.
Crossref
Crossref
Rita Esquivel-PérezLeticia Moreno-Fierros. (2005) Mucosal and Systemic Adjuvant Effects of Cholera Toxin and Cry1Ac Protoxin on the Specific Antibody Response to HIV-1 C4/V3 Peptides Are Different and Depend on the Antigen Co-administered. Viral Immunology 18:4, pages 695-708.
Crossref
Crossref
Jeffrey R. Kovacs, Ying Zheng, Hongmei Shen & Wilson S. Meng. (2005) Polymeric microspheres as stabilizing anchors for oligonucleotide delivery to dendritic cells. Biomaterials 26:33, pages 6754-6761.
Crossref
Crossref
Xiaowen He, Lei Jiang, Fang Wang, Zhenyu Xiao, Jun Li, Liu Shankui Liu, Dean Li, Ding Ren, Xiaoqin Jin, Kai Li, Yin He, Ke Shi, Yingjun Guo, Yanan Zhang & Shuhan Sun. (2005) Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles. Journal of Controlled Release 107:2, pages 357-372.
Crossref
Crossref
Wyatt Byrd, Arthur de Lorimier, Zi-Rong Zheng & Frederick J. Cassels. (2005) Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens. Advanced Drug Delivery Reviews 57:9, pages 1362-1380.
Crossref
Crossref
Xiao-Wen He, Fang Wang, Lei Jiang, Jun Li, Shan-kui Liu, Zhen-Yu Xiao, Xiao-Qin Jin, Ya-Nan Zhang, Ying He, Kai Li, Ying-Jun Guo & Shu-Han Sun. (2005) Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. Journal of General Virology 86:3, pages 601-610.
Crossref
Crossref
Derek T. O'Hagan, Manmohan Singh & Jeffrey B. Ulmer. (2004) Microparticles for the delivery of DNA vaccines. Immunological Reviews 199:1, pages 191-200.
Crossref
Crossref
Marisa Peyre, Roland Fleck, David Hockley, Bruno Gander & Dorothea Sesardic. (2004) In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation. Vaccine 22:19, pages 2430-2437.
Crossref
Crossref
Manmohan Singh, Jina Kazzaz, James Chesko, Elawati Soenawan, Mildred Ugozzoli, Marzia Giuliani, Mariagrazia Pizza, Rino Rappouli & Derek T. O'Hagan. (2004) Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. Journal of Pharmaceutical Sciences 93:2, pages 273-282.
Crossref
Crossref
Derek T. O'Hagan & Nicholas M. Valiante. (2003) Recent advances in the discovery and delivery of vaccine adjuvants. Nature Reviews Drug Discovery 2:9, pages 727-735.
Crossref
Crossref